Producer
Divi's Laboratories Limited
Indian pharmaceutical API manufacturer (NSE: DIVISLAB, HQ Hyderabad; ~₹75B revenue); one of India's largest and most technically sophisticated pharmaceutical API producers, specializing in complex APIs including fluoroquinolones (ciprofloxacin, ofloxacin, levofloxacin), carotenoids (nutraceuticals), and custom synthesis for branded pharmaceutical companies. Divi's Laboratories has never been involved in a major USFDA warning letter or import alert (unusual for an Indian API company of its scale) — maintaining essentially clean regulatory compliance across its multiple Visakhapatnam, Andhra Pradesh production facilities. Divi's produces fluoroquinolone APIs including ciprofloxacin HCl for ophthalmic applications for global generic pharmaceutical customers. Divi's is also one of India's most consistently profitable pharmaceutical companies — its focus on volume API production at high quality has created a near-uninterruptible supply chain position across multiple essential medicines.
4
Inputs supplied
3
Goods downstream
1
Facilities
0
Stories
What they make
4 inputs Divi's Laboratories Limited supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
pharmaceutical
Fluoroquinolone APIs (ciprofloxacin HCl, ofloxacin, moxifloxacin HCl) →
chemical
Pharmaceutical Key Starting Materials (KSMs) →
pharmaceutical
Corticosteroid APIs (betamethasone, clobetasol, triamcinolone) →
pharmaceutical
Tretinoin (all-trans retinoic acid) API →
Where it shows up
Goods downstream
Essential goods that depend on something Divi's Laboratories Limited makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Generic APIs
55%Custom Synthesis (Pharma CDMO)
30%Nutraceuticals (Carotenoids)
15%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Did you know2024
Divi's Laboratories is understood globally as a pharmaceutical API company — ciprofloxacin, naproxen, and other bulk APIs for generic drug manufacturers. What the supplement and nutraceutical industry knows separately is that Divi's is also one of India's largest carotenoid producers (beta-carotene, astaxanthin, lutein) for food fortification and dietary supplements. The beta-carotene in a vitamin A supplement and the ciprofloxacin in a generic antibiotic may both originate from the same Hyderabad company. Beyond this dual pharma/nutraceutical position, Divi's is a significant custom synthesis provider for branded innovator pharmaceutical companies — it synthesizes proprietary APIs and key starting materials for global pharma majors including MSD, Pfizer, and Roche under confidential contracts. Divi's thus simultaneously serves the generic API market (volume) and the innovator custom synthesis market (value) and the nutraceutical market (specialty), making it one of India's most diversified pharmaceutical chemistry businesses despite being classified as an "API company" in most industry databases.
Divi's Laboratories Limited ↗Origin2023
Divi's Laboratories was founded in 1990 in Hyderabad by Dr. Murali Krishna Divi — a chemist who had worked in the US pharmaceutical industry before returning to India to build an API manufacturing company. The founding philosophy was quality-first and compliance-driven at a time when most Indian pharma API companies competed primarily on cost. Divi's built its Visakhapatnam manufacturing complex on the Andhra Pradesh coast specifically to access deep water port infrastructure for API bulk export, and invested heavily in analytical capabilities and environmental management systems that were unusual for Indian API companies of the era. The result: Divi's has maintained a near-clean FDA compliance record through decades of inspections while scaling to one of India's largest API revenue producers — a model of quality-competitive Indian pharmaceutical manufacturing rarely replicated at equivalent scale.
Divi's Laboratories Limited ↗